The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

Purdue Pharma developed and aggressively marketed OxyContin starting in the 1990s via medical sales reps whose job was to convince doctors to prescribe more of their drug. Inappropriate ...

Kaitlyn Dever has quickly emerged as one of the standout stars of her generation, establishing herself as one of the most ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial contribution to resolve mass opioid litigation. The Sacklers and Purdue Pharma ...

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

Registration is open for faculty to attend the Westwood Lecture Series on Feb. 19. Two leading Purdue researchers will discuss the university’s growing role in the next revolution of ...

The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...